Report cover image

Global In Vitro Diagnostic Devices Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 213 Pages
SKU # APRC20361575

Description

Summary

According to APO Research, The global In Vitro Diagnostic Devices market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for In Vitro Diagnostic Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for In Vitro Diagnostic Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for In Vitro Diagnostic Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for In Vitro Diagnostic Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of In Vitro Diagnostic Devices include Abbott, Thermo Fisher Scientific, Roche, Wondfo, Sysmex, Siemens Healthineers, Qiagen, Ortho Clinical Diagnostics and Myriad Genetics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for In Vitro Diagnostic Devices, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of In Vitro Diagnostic Devices, also provides the revenue of main regions and countries. Of the upcoming market potential for In Vitro Diagnostic Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the In Vitro Diagnostic Devices revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global In Vitro Diagnostic Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for In Vitro Diagnostic Devices revenue, projected growth trends, production technology, application and end-user industry.

In Vitro Diagnostic Devices Segment by Company

Abbott
Thermo Fisher Scientific
Roche
Wondfo
Sysmex
Siemens Healthineers
Qiagen
Ortho Clinical Diagnostics
Myriad Genetics
Mindray
LG Chem
Leadman Biochemistry
KHB
Johnson and Johnson
Hologic
Danaher
DAAN Gene
BioSino
Bio-Rad Laboratories
Biomerieux
Becton Dickinson
In Vitro Diagnostic Devices Segment by Type

POCT
Molecular Diagnostics
Chemistry Diagnostics
Immuno Diagnostics
Other
In Vitro Diagnostic Devices Segment by Application

Hospitals
Laboratory
Other
In Vitro Diagnostic Devices Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Diagnostic Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vitro Diagnostic Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Diagnostic Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of In Vitro Diagnostic Devices in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of In Vitro Diagnostic Devices company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In Vitro Diagnostic Devices revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

213 Pages
1 Market Overview
1.1 Product Definition
1.2 In Vitro Diagnostic Devices Market by Type
1.2.1 Global In Vitro Diagnostic Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 POCT
1.2.3 Molecular Diagnostics
1.2.4 Chemistry Diagnostics
1.2.5 Immuno Diagnostics
1.2.6 Other
1.3 In Vitro Diagnostic Devices Market by Application
1.3.1 Global In Vitro Diagnostic Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Laboratory
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 In Vitro Diagnostic Devices Market Dynamics
2.1 In Vitro Diagnostic Devices Industry Trends
2.2 In Vitro Diagnostic Devices Industry Drivers
2.3 In Vitro Diagnostic Devices Industry Opportunities and Challenges
2.4 In Vitro Diagnostic Devices Industry Restraints
3 Global Growth Perspective
3.1 Global In Vitro Diagnostic Devices Market Perspective (2020-2031)
3.2 Global In Vitro Diagnostic Devices Growth Trends by Region
3.2.1 Global In Vitro Diagnostic Devices Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global In Vitro Diagnostic Devices Market Size by Region (2020-2025)
3.2.3 Global In Vitro Diagnostic Devices Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global In Vitro Diagnostic Devices Revenue by Players
4.1.1 Global In Vitro Diagnostic Devices Revenue by Players (2020-2025)
4.1.2 Global In Vitro Diagnostic Devices Revenue Market Share by Players (2020-2025)
4.1.3 Global In Vitro Diagnostic Devices Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global In Vitro Diagnostic Devices Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global In Vitro Diagnostic Devices Key Players Headquarters & Area Served
4.4 Global In Vitro Diagnostic Devices Players, Product Type & Application
4.5 Global In Vitro Diagnostic Devices Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global In Vitro Diagnostic Devices Market CR5 and HHI
4.6.3 2024 In Vitro Diagnostic Devices Tier 1, Tier 2, and Tier 3
5 In Vitro Diagnostic Devices Market Size by Type
5.1 Global In Vitro Diagnostic Devices Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global In Vitro Diagnostic Devices Revenue by Type (2020-2031)
5.3 Global In Vitro Diagnostic Devices Revenue Market Share by Type (2020-2031)
6 In Vitro Diagnostic Devices Market Size by Application
6.1 Global In Vitro Diagnostic Devices Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global In Vitro Diagnostic Devices Revenue by Application (2020-2031)
6.3 Global In Vitro Diagnostic Devices Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Comapny Information
7.1.2 Abbott Business Overview
7.1.3 Abbott In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.1.4 Abbott In Vitro Diagnostic Devices Product Portfolio
7.1.5 Abbott Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Comapny Information
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.2.4 Thermo Fisher Scientific In Vitro Diagnostic Devices Product Portfolio
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 Roche
7.3.1 Roche Comapny Information
7.3.2 Roche Business Overview
7.3.3 Roche In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.3.4 Roche In Vitro Diagnostic Devices Product Portfolio
7.3.5 Roche Recent Developments
7.4 Wondfo
7.4.1 Wondfo Comapny Information
7.4.2 Wondfo Business Overview
7.4.3 Wondfo In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.4.4 Wondfo In Vitro Diagnostic Devices Product Portfolio
7.4.5 Wondfo Recent Developments
7.5 Sysmex
7.5.1 Sysmex Comapny Information
7.5.2 Sysmex Business Overview
7.5.3 Sysmex In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.5.4 Sysmex In Vitro Diagnostic Devices Product Portfolio
7.5.5 Sysmex Recent Developments
7.6 Siemens Healthineers
7.6.1 Siemens Healthineers Comapny Information
7.6.2 Siemens Healthineers Business Overview
7.6.3 Siemens Healthineers In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.6.4 Siemens Healthineers In Vitro Diagnostic Devices Product Portfolio
7.6.5 Siemens Healthineers Recent Developments
7.7 Qiagen
7.7.1 Qiagen Comapny Information
7.7.2 Qiagen Business Overview
7.7.3 Qiagen In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.7.4 Qiagen In Vitro Diagnostic Devices Product Portfolio
7.7.5 Qiagen Recent Developments
7.8 Ortho Clinical Diagnostics
7.8.1 Ortho Clinical Diagnostics Comapny Information
7.8.2 Ortho Clinical Diagnostics Business Overview
7.8.3 Ortho Clinical Diagnostics In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.8.4 Ortho Clinical Diagnostics In Vitro Diagnostic Devices Product Portfolio
7.8.5 Ortho Clinical Diagnostics Recent Developments
7.9 Myriad Genetics
7.9.1 Myriad Genetics Comapny Information
7.9.2 Myriad Genetics Business Overview
7.9.3 Myriad Genetics In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.9.4 Myriad Genetics In Vitro Diagnostic Devices Product Portfolio
7.9.5 Myriad Genetics Recent Developments
7.10 Mindray
7.10.1 Mindray Comapny Information
7.10.2 Mindray Business Overview
7.10.3 Mindray In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.10.4 Mindray In Vitro Diagnostic Devices Product Portfolio
7.10.5 Mindray Recent Developments
7.11 LG Chem
7.11.1 LG Chem Comapny Information
7.11.2 LG Chem Business Overview
7.11.3 LG Chem In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.11.4 LG Chem In Vitro Diagnostic Devices Product Portfolio
7.11.5 LG Chem Recent Developments
7.12 Leadman Biochemistry
7.12.1 Leadman Biochemistry Comapny Information
7.12.2 Leadman Biochemistry Business Overview
7.12.3 Leadman Biochemistry In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.12.4 Leadman Biochemistry In Vitro Diagnostic Devices Product Portfolio
7.12.5 Leadman Biochemistry Recent Developments
7.13 KHB
7.13.1 KHB Comapny Information
7.13.2 KHB Business Overview
7.13.3 KHB In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.13.4 KHB In Vitro Diagnostic Devices Product Portfolio
7.13.5 KHB Recent Developments
7.14 Johnson and Johnson
7.14.1 Johnson and Johnson Comapny Information
7.14.2 Johnson and Johnson Business Overview
7.14.3 Johnson and Johnson In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.14.4 Johnson and Johnson In Vitro Diagnostic Devices Product Portfolio
7.14.5 Johnson and Johnson Recent Developments
7.15 Hologic
7.15.1 Hologic Comapny Information
7.15.2 Hologic Business Overview
7.15.3 Hologic In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.15.4 Hologic In Vitro Diagnostic Devices Product Portfolio
7.15.5 Hologic Recent Developments
7.16 Danaher
7.16.1 Danaher Comapny Information
7.16.2 Danaher Business Overview
7.16.3 Danaher In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.16.4 Danaher In Vitro Diagnostic Devices Product Portfolio
7.16.5 Danaher Recent Developments
7.17 DAAN Gene
7.17.1 DAAN Gene Comapny Information
7.17.2 DAAN Gene Business Overview
7.17.3 DAAN Gene In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.17.4 DAAN Gene In Vitro Diagnostic Devices Product Portfolio
7.17.5 DAAN Gene Recent Developments
7.18 BioSino
7.18.1 BioSino Comapny Information
7.18.2 BioSino Business Overview
7.18.3 BioSino In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.18.4 BioSino In Vitro Diagnostic Devices Product Portfolio
7.18.5 BioSino Recent Developments
7.19 Bio-Rad Laboratories
7.19.1 Bio-Rad Laboratories Comapny Information
7.19.2 Bio-Rad Laboratories Business Overview
7.19.3 Bio-Rad Laboratories In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.19.4 Bio-Rad Laboratories In Vitro Diagnostic Devices Product Portfolio
7.19.5 Bio-Rad Laboratories Recent Developments
7.20 Biomerieux
7.20.1 Biomerieux Comapny Information
7.20.2 Biomerieux Business Overview
7.20.3 Biomerieux In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.20.4 Biomerieux In Vitro Diagnostic Devices Product Portfolio
7.20.5 Biomerieux Recent Developments
7.21 Becton Dickinson
7.21.1 Becton Dickinson Comapny Information
7.21.2 Becton Dickinson Business Overview
7.21.3 Becton Dickinson In Vitro Diagnostic Devices Revenue and Gross Margin (2020-2025)
7.21.4 Becton Dickinson In Vitro Diagnostic Devices Product Portfolio
7.21.5 Becton Dickinson Recent Developments
8 North America
8.1 North America In Vitro Diagnostic Devices Revenue (2020-2031)
8.2 North America In Vitro Diagnostic Devices Revenue by Type (2020-2031)
8.2.1 North America In Vitro Diagnostic Devices Revenue by Type (2020-2025)
8.2.2 North America In Vitro Diagnostic Devices Revenue by Type (2026-2031)
8.3 North America In Vitro Diagnostic Devices Revenue Share by Type (2020-2031)
8.4 North America In Vitro Diagnostic Devices Revenue by Application (2020-2031)
8.4.1 North America In Vitro Diagnostic Devices Revenue by Application (2020-2025)
8.4.2 North America In Vitro Diagnostic Devices Revenue by Application (2026-2031)
8.5 North America In Vitro Diagnostic Devices Revenue Share by Application (2020-2031)
8.6 North America In Vitro Diagnostic Devices Revenue by Country
8.6.1 North America In Vitro Diagnostic Devices Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America In Vitro Diagnostic Devices Revenue by Country (2020-2025)
8.6.3 North America In Vitro Diagnostic Devices Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe In Vitro Diagnostic Devices Revenue (2020-2031)
9.2 Europe In Vitro Diagnostic Devices Revenue by Type (2020-2031)
9.2.1 Europe In Vitro Diagnostic Devices Revenue by Type (2020-2025)
9.2.2 Europe In Vitro Diagnostic Devices Revenue by Type (2026-2031)
9.3 Europe In Vitro Diagnostic Devices Revenue Share by Type (2020-2031)
9.4 Europe In Vitro Diagnostic Devices Revenue by Application (2020-2031)
9.4.1 Europe In Vitro Diagnostic Devices Revenue by Application (2020-2025)
9.4.2 Europe In Vitro Diagnostic Devices Revenue by Application (2026-2031)
9.5 Europe In Vitro Diagnostic Devices Revenue Share by Application (2020-2031)
9.6 Europe In Vitro Diagnostic Devices Revenue by Country
9.6.1 Europe In Vitro Diagnostic Devices Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe In Vitro Diagnostic Devices Revenue by Country (2020-2025)
9.6.3 Europe In Vitro Diagnostic Devices Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China In Vitro Diagnostic Devices Revenue (2020-2031)
10.2 China In Vitro Diagnostic Devices Revenue by Type (2020-2031)
10.2.1 China In Vitro Diagnostic Devices Revenue by Type (2020-2025)
10.2.2 China In Vitro Diagnostic Devices Revenue by Type (2026-2031)
10.3 China In Vitro Diagnostic Devices Revenue Share by Type (2020-2031)
10.4 China In Vitro Diagnostic Devices Revenue by Application (2020-2031)
10.4.1 China In Vitro Diagnostic Devices Revenue by Application (2020-2025)
10.4.2 China In Vitro Diagnostic Devices Revenue by Application (2026-2031)
10.5 China In Vitro Diagnostic Devices Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia In Vitro Diagnostic Devices Revenue (2020-2031)
11.2 Asia In Vitro Diagnostic Devices Revenue by Type (2020-2031)
11.2.1 Asia In Vitro Diagnostic Devices Revenue by Type (2020-2025)
11.2.2 Asia In Vitro Diagnostic Devices Revenue by Type (2026-2031)
11.3 Asia In Vitro Diagnostic Devices Revenue Share by Type (2020-2031)
11.4 Asia In Vitro Diagnostic Devices Revenue by Application (2020-2031)
11.4.1 Asia In Vitro Diagnostic Devices Revenue by Application (2020-2025)
11.4.2 Asia In Vitro Diagnostic Devices Revenue by Application (2026-2031)
11.5 Asia In Vitro Diagnostic Devices Revenue Share by Application (2020-2031)
11.6 Asia In Vitro Diagnostic Devices Revenue by Country
11.6.1 Asia In Vitro Diagnostic Devices Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia In Vitro Diagnostic Devices Revenue by Country (2020-2025)
11.6.3 Asia In Vitro Diagnostic Devices Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA In Vitro Diagnostic Devices Revenue (2020-2031)
12.2 SAMEA In Vitro Diagnostic Devices Revenue by Type (2020-2031)
12.2.1 SAMEA In Vitro Diagnostic Devices Revenue by Type (2020-2025)
12.2.2 SAMEA In Vitro Diagnostic Devices Revenue by Type (2026-2031)
12.3 SAMEA In Vitro Diagnostic Devices Revenue Share by Type (2020-2031)
12.4 SAMEA In Vitro Diagnostic Devices Revenue by Application (2020-2031)
12.4.1 SAMEA In Vitro Diagnostic Devices Revenue by Application (2020-2025)
12.4.2 SAMEA In Vitro Diagnostic Devices Revenue by Application (2026-2031)
12.5 SAMEA In Vitro Diagnostic Devices Revenue Share by Application (2020-2031)
12.6 SAMEA In Vitro Diagnostic Devices Revenue by Country
12.6.1 SAMEA In Vitro Diagnostic Devices Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA In Vitro Diagnostic Devices Revenue by Country (2020-2025)
12.6.3 SAMEA In Vitro Diagnostic Devices Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.